← Browse by Condition
Medical Condition
kidney transplant
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 4, Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for kidney transplant sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — kidney transplant Clinical Trials
How many clinical trials are currently recruiting for kidney transplant?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for kidney transplant, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for kidney transplant?
kidney transplant research spans Phase 2 (2 trials), Phase 3 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a kidney transplant clinical trial?
Eligibility criteria for kidney transplant trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 2
Phase 3 1
Phase 4 2
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07266467 Phase 4
Recruiting
Enrollment
290 pts
Location
China
Sponsor
First Affiliated Hospital Xi'a...
NCT07760402
Recruiting
Enrollment
34 pts
Location
Turkey (Türkiye)
Sponsor
University of Gaziantep
NCT06055608 Phase 2
Recruiting
Enrollment
200 pts
Location
United States
Sponsor
National Institute of Allergy ...
NCT06288152
Recruiting
Enrollment
120 pts
Location
Canada
Sponsor
Alp Sener
NCT06013865 Phase 4
Recruiting
Enrollment
264 pts
Location
United States
Sponsor
VA Office of Research and Deve...
NCT07011238
Recruiting
Enrollment
51 pts
Location
France
Sponsor
University Hospital, Rouen
NCT07291258
Recruiting
Enrollment
200 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
NCT06919003 Phase 2
Recruiting
Enrollment
180 pts
Location
United States
Sponsor
National Institute of Allergy ...
NCT06830798 Phase 3
Recruiting
Enrollment
450 pts
Location
United States, Argen...
Sponsor
Alexion Pharmaceuticals, Inc.
NCT06794970
Recruiting
Enrollment
50 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology